Skip to content
Back to BIVIW

Biovie Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
5
Purchases
5
Sales
0
Purchase value
$52.02K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Cuong DO VDirector · President & CEO
4
Filed Nov 16, 2026Period of report Nov 13, 20260001520138-26-000490
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 13, 2026
Common StockF12,500$1.1625$2.91K18,617Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on November 13, 2026, at prices ranging from $1.1600 to $1.1650, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Joseph M PalumboChief Medical Officer
4
Filed Aug 28, 2026Period of report Aug 28, 20260001520138-26-000383
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 28, 2026
Common StockF14,843$2.16$10.46K6,036Direct
Filing footnotes · 1
  1. F1The shares of Common Stock were purchased in several open market transactions, all at the same price. The reported price does not reflect a weighted average price.
Open on SEC EDGAR
Amy Suzon ChappellDirector
4
Filed Aug 28, 2026Period of report Aug 28, 20260001520138-26-000382
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 28, 2026
Common StockF1727$2.16$1.57K727Direct
Filing footnotes · 1
  1. F1The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Open on SEC EDGAR
Joanne Wendy KIMChief Financial Officer
4
Filed Aug 28, 2026Period of report Aug 28, 20260001520138-26-000379
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 28, 2026
Common StockF12,500$2.18$5.45K3,441Direct
Filing footnotes · 1
  1. F1The shares of Common Stock were purchased by the Reporting Person in an open market transaction.
Open on SEC EDGAR
Cuong DO VDirector · President & CEO
4
Filed Aug 28, 2026Period of report Aug 27, 20260001520138-26-000378
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 27, 2026
Common StockF115,210$2.08$31.64K16,117Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price at which shares were purchased in several open market transactions on August 27, 2026, at prices ranging from $2.05 to $2.10, inclusive. The reporting person undertakes to provide BioVie Inc., any stockholder of BioVie Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.